Adjuvant radiotherapy has no benefit following radical prostatectomy
Dr Pramesh speaks with ecancer at EBMCI 2017 about the National Cancer Grid.
He introduces the cancer guidelines developed within the consortium, and considers institutional peer-review within member centres as a means of maintaining standards.
Dr Pramesh also describes different means of knowledge sharing between peers, online, and endeavours to share updates with geographically remote oncologists across the country.
Adjuvant radiotherapy has no benefit following radical prostatectomy
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours